Sector News

Monsanto bid may mean Bayer will cut pharma R&D spending

June 1, 2016
Energy & Chemical Value Chain

The proposed $62bn merger with agrochemical firm Monsanto would jeopardise Bayer’s pharmaceutical business, according to a BMI Research analyst.

> Read the full article on the in-Pharma Technologist website

By Dan Stanton

Source: in-Pharma Technologist

comments closed

Related News

March 16, 2025

OMV receives EU funding for large-scale chemical-recycling plant

Energy & Chemical Value Chain

OMV AG and the European Climate, Infrastructure and Environment Executive Agency (CINEA) have signed a grant agreement for OMV’s planned industrial ReOil plant, securing up to €81.6 million funding. This marks the first time that OMV receives a grant from the EU Innovation Fund.

March 16, 2025

Vopak doubles industrial, gas terminals investment to €2B by 2030

Energy & Chemical Value Chain

Vopak has previously committed investment of up to €1 billion in the sector to achieve its growth ambitions by the end of this decade, but it announced in a capital markets event for investors on March 13 that it will double its planned spending in industrial and gas terminals.

March 16, 2025

5 reasons mechanical recycling is great for plastic film

Energy & Chemical Value Chain

As many know, we are building our first plastic film recycling facility in Connersville, Indiana. We expect our first line to be operational in the coming weeks. Want to know why I think mechanical recycling is the best technology for polyethylene film? Here are five reasons mechanical recycling is a great choice.

How can we help you?

We're easy to reach